Pre- and post- flu human sera
Active Definitive Contract Awarded Last action
- Contract number
- 75D30124C19866
- Awardee
-
Navitas Clinical Research Inc. UEI HA8KGRBJZNM8
- Awarding agency
-
CDC Pittsburgh
Centers for Disease Control and Prevention, Department of Health and Human Services
- Obligated
- $4,184,930
Award facts
- Opportunity
-
- Pre- and Post- Influenza Human Sera Panels Solicitation · 75D30124Q77727 · Posted Jul 17, 2024
- Contract value 58% obligated
-
- $4,184,930.00 Current, with exercised options
- $7,176,341.00 Potential, with all options
- Completion date 43% complete
-
- Current, with exercised options
- Potential, with all options
- Contracting staff
- NAICS code
- 621511 Medical Laboratories
- PSC
- R499 Support- Professional: Other
- Set-aside
- No set-aside
- Competition
- Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Atlanta, GA 30329, USA
- Legislative mandates
-
- Service Contract Act FAR subpart 22.10
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Exercise an Option | $1,430,406 | |
| Other Administrative Action | $0 | |
| Exercise an Option | $1,388,618 | |
| Original award | $1,365,906 |
About this award
The Centers for Disease Control and Prevention awarded a $7.176 million definitive contract to Navitas Clinical Research Inc. for collection of pre- and post-influenza vaccination serum samples on September 5, 2024, under firm fixed pricing with no set-aside.
The originating solicitation calls for anonymous blood collection from six age cohorts—young pediatric, older pediatric, adolescent, adult, older adult, and elderly—to evaluate vaccine effectiveness against newly circulating influenza virus strains. Samples are collected before and 21–28 days after seasonal influenza vaccination; young pediatric and older pediatric participants requiring two doses have post-vaccination samples collected after the second dose. The contract also requires provision of large-volume post-vaccination serum samples from adult participants for further testing. Place of performance is Atlanta, Georgia. The contract runs through September 3, 2029, with a one-year base period and four one-year option periods. In fiscal 2024, Navitas invoiced $114 thousand across 92 contractor hours at a derived rate of $1,243.99 per hour, self-performing all reported work with no subcontractors.
Quick answers
Who was awarded contract 75D30124C19866?
75D30124C19866 was awarded to Navitas Clinical Research Inc. by CDC Pittsburgh (Centers for Disease Control and Prevention) on September 5, 2024.
How much is contract 75D30124C19866 worth?
The government has obligated $4,184,930 on 75D30124C19866. Its potential value, with all options, is $7,176,341.
Was contract 75D30124C19866 competed?
The extent of competition for 75D30124C19866 was competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award